Anu Skog

Immunogenicity of granulocyte-macrophage colony-stimulating factor (GM-CSF) products in patients undergoing combination therapy with GM-CSF.

Meenu Wadhwa, Anu Skog, Chris Bird et al. · PubMed · 1999 · 81 citations

Clinical Immunology, Immunology, Pathology +19

Long‐term vegetation changes of treeless heath communities in northern Fennoscandia: Links to climate change trends and reindeer grazing

Tuija Maliniemi, Jutta Kapfer, Patrick Saccone et al. · Journal of Vegetation Science · 2018 · 76 citations

Climatology, Reindeer Grazing, Engineering +13

Juvenile pathogen exposure affects the presence of personality in adult field crickets

Nicholas DiRienzo, Petri T. Niemelä, Anu Skog et al. · Frontiers in Ecology and Evolution · 2015 · 35 citations · Full text

Fitness, Individual Differences, Education +17

Alteration of interleukin 2 (IL-2) pharmacokinetics and function by IL-2 antibodies induced after treatment of colorectal carcinoma patients with a combination of monoclonal antibody 17-1A, granulocyte macrophage colony-stimulating factor, and IL-2.

Anu Skog, Meenu Wadhwa, Moustapha Hassan et al. · PubMed · 2001 · 25 citations

Inflammation, Cytokine, Il-2 Therapy +15

Clinical effects of monoclonal antibody 17-1A combined with granulocyte/macrophage-colony-stimulating factor and interleukin-2 for treatment of patients with advanced colorectal carcinoma

Anu Skog, Peter Ragnhammar, Jan Fagerberg et al. · Cancer Immunology Immunotherapy · 1999 · 24 citations · Full text

Medicine, Immunology, Colorectal Cancer +9